Tiny study tests safety of novel dead bacterium in healthy volunteers
NCT ID NCT07660107
First seen Jun 23, 2026 · Last updated Jun 23, 2026
Summary
This completed trial tested whether a heat-killed bacterium called KGA-10 (NeuroAlly) is safe and tolerable for healthy adults. Eight participants took either KGA-10 or a placebo daily for one week. Researchers tracked side effects and satisfaction using surveys. The study was very small and only looked at safety, not any health benefits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TOLERABILITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Colorado, Boulder - WILD campus
Boulder, Colorado, 80301, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Heat-killed Mycolicibacterium petrae KGA-10 (a type of dead bacteria, also called NeuroAlly)
What this could lead to
If safe, this could pave the way for future studies testing KGA-10 for other health conditions.
What could go wrong
This was a very small, early safety study with only 8 people. It does not test whether KGA-10 has any health benefits.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.